Lux Capital
Founded in 2000, Lux Capital is a venture capital firm based in New York and Silicon Valley. It manages over $5 billion in assets, focusing on seed to growth investments at the intersection of technology and sciences. Lux actively supports entrepreneurs building successful businesses in high-growth sectors such as biochemistry, material science, electronics, infrastructure, aerospace, genomics, synthetic biology, and robotics.
Top Sectors
Top Regions
https://crunchbase.com/organization/***
https://linkedin.com/company/***
https://signal.nfx.com/firms/***
Past deals in Wearables
Cala Health
Series C in 2024
Cala Health is a bioelectronic medicine company that develops wearable neuromodulation therapies for chronic diseases. Its primary product, Cala Trio therapy, is a non-invasive prescription treatment for essential tremor.
Miga
Seed Round in 2022
Miga is a virtual cardiometabolic clinic offering a gamified mobile app for managing obesity, hypertension, diabetes, and hyperlipidemia. It combines clinical services such as labs, devices, pharmacy, and lifestyle coaching.
Cala Health
Series C in 2019
Cala Health is a bioelectronic medicine company that develops wearable neuromodulation therapies for chronic diseases. Its primary product, Cala Trio therapy, is a non-invasive prescription treatment for essential tremor.
CTRL-Labs
Venture Round in 2019
CTRL-Labs develops neural interface technologies that enable humans to interact with machines using natural movements and thoughts. Their flagship product, CTRL-kit, is a wireless, non-invasive electromyography device that translates neural signals into control for applications in XR, robotics, productivity, and clinical research.
CTRL-Labs
Series B in 2018
CTRL-Labs develops neural interface technologies that enable humans to interact with machines using natural movements and thoughts. Their flagship product, CTRL-kit, is a wireless, non-invasive electromyography device that translates neural signals into control for applications in XR, robotics, productivity, and clinical research.
Aira
Series B in 2017
Aira offers on-demand visual interpretation services for individuals who are blind or have low vision. Users can access trained professionals via a mobile app, enabling them to navigate daily tasks more independently.
Aira
Series A in 2016
Aira offers on-demand visual interpretation services for individuals who are blind or have low vision. Users can access trained professionals via a mobile app, enabling them to navigate daily tasks more independently.
Cala Health
Series B in 2016
Cala Health is a bioelectronic medicine company that develops wearable neuromodulation therapies for chronic diseases. Its primary product, Cala Trio therapy, is a non-invasive prescription treatment for essential tremor.
Aira
Seed Round in 2015
Aira offers on-demand visual interpretation services for individuals who are blind or have low vision. Users can access trained professionals via a mobile app, enabling them to navigate daily tasks more independently.
Cala Health
Series A in 2014
Cala Health is a bioelectronic medicine company that develops wearable neuromodulation therapies for chronic diseases. Its primary product, Cala Trio therapy, is a non-invasive prescription treatment for essential tremor.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.